Marshall Wace, LLP Avanos Medical, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 64,765 shares of AVNS stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,765Holding current value
$1.07 Million% of portfolio
0.0%Shares
19 transactions
Others Institutions Holding AVNS
# of Institutions
273Shares Held
43.3MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.34MShares$88.5 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.01MShares$49.9 Million0.03% of portfolio
-
Rgm Capital, LLC Naples, FL2.99MShares$49.5 Million1.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$42.7 Million0.01% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $770M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...